Pages that link to "Q34654793"
Jump to navigation
Jump to search
The following pages link to Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences (Q34654793):
Displaying 29 items.
- Next-generation sequencing: hype and hope for development of personalized radiation therapy? (Q26796485) (← links)
- On metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer (Q28072798) (← links)
- Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes (Q28554412) (← links)
- Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. (Q34550417) (← links)
- Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer. (Q35833567) (← links)
- A laser microdissection-based workflow for FFPE tissue microproteomics: important considerations for small sample processing (Q35874335) (← links)
- Clinical implications of molecular heterogeneity in triple negative breast cancer. (Q36271396) (← links)
- Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification. (Q38647802) (← links)
- The Utilization of Formalin Fixed-Paraffin-Embedded Specimens in High Throughput Genomic Studies. (Q38752220) (← links)
- Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis. (Q38875037) (← links)
- Targeted next-generation sequencing enables reliable detection of HER2 (ERBB2) status in breast cancer and provides ancillary information of clinical relevance (Q39238692) (← links)
- Frequent PIK3CA activating mutations in nipple adenomas. (Q39577466) (← links)
- Exploring phenotype patterns of breast cancer within somatic mutations: a modicum in the intrinsic code (Q39752527) (← links)
- Anti-androgen therapy in triple-negative breast cancer (Q41813668) (← links)
- Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling. (Q43635406) (← links)
- Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology (Q46759303) (← links)
- Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics. (Q48157504) (← links)
- Targeted deep sequencing of effusion cytology samples is feasible, informs spatiotemporal tumor evolution, and has clinical and diagnostic utility. (Q48167974) (← links)
- Association between obesity with disease-free survival and overall survival in triple-negative breast cancer: A meta-analysis. (Q55194330) (← links)
- Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer. (Q55210260) (← links)
- Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. (Q55428234) (← links)
- Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer (Q58725505) (← links)
- ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer (Q64389037) (← links)
- MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial (Q89592800) (← links)
- Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments (Q90632786) (← links)
- KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival (Q91713151) (← links)
- Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells (Q91892950) (← links)
- High prevalence of the MLH1 V384D germline mutation in patients with HER2-positive luminal B breast cancer (Q92266340) (← links)
- EGFR, BRCA1, BRCA2 and TP53 genetic profile in Moroccan triple negative breast cancer cases (Q97884515) (← links)